Efficacy and safety of 3CL protease inhibitors in patients with mild or moderate COVID-19: a systematic review and meta-analysis of randomized controlled trials.

IF 4 3区医学 Q2 VIROLOGY

Virology Journal Pub Date : 2025-08-21 DOI:10.1186/s12985-025-02899-0

Nicole Jean Lee, Eric Shih Katsuyama, Christian Ken Fukunaga, Wilson Falco Neto, Ana Carolina Covre Coan, Hilaria Saugo Faria, Eduardo Alexandrino Medeiros

引用次数: 0

Abstract Image

查看原文本刊更多论文

3CL蛋白酶抑制剂对轻中度COVID-19患者的疗效和安全性：随机对照试验的系统评价和荟萃分析

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Virology Journal 医学-病毒学

CiteScore

7.40

自引率

2.10%

发文量

186

审稿时长

1 months

期刊介绍： Virology Journal is an open access, peer reviewed journal that considers articles on all aspects of virology, including research on the viruses of animals, plants and microbes. The journal welcomes basic research as well as pre-clinical and clinical studies of novel diagnostic tools, vaccines and anti-viral therapies. The Editorial policy of Virology Journal is to publish all research which is assessed by peer reviewers to be a coherent and sound addition to the scientific literature, and puts less emphasis on interest levels or perceived impact.